Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-xbtfd Total loading time: 0 Render date: 2024-11-17T14:36:00.778Z Has data issue: false hasContentIssue false

15 - Pediatric movement disorders

Published online by Cambridge University Press:  13 August 2009

Scott J. Hunter
Affiliation:
University of Chicago
Jacobus Donders
Affiliation:
Mary Free Bed Rehabilitation Hospital, Grand Rapids
Get access

Summary

Movement disorders are seldom considered when discussing pediatric neuropsychological disorders, despite their common presentation in a number of childhood conditions. This lack of consideration is most likely due to the general awareness that the quintessential movement disorders are ones known to primarily affect aging individuals, i.e. Parkinson and Huntington disorders. Hence, it is often surprising to pediatric neuropsychologists in training, as well as to persons outside the field, that Huntington disorder can arise in children and adolescents. Similarly, it is often a novel consideration for non-physicians that a well discussed neuropsychiatric disorder such as Tourette syndrome (TS) is most appropriately classified as a movement disorder, in response to its neurological etiology and attendant symptoms. Thus, there is a fairly wide “hole” in the neuropsychological literature in terms of understanding pediatric movement disorders and how they can be distinguished from disorders of motor control and executive functioning (see chapters in this volume by Tupper and by Mahone and Slomine). This is an interesting observation, given an increased interest in the pediatric movement disorders and advances in identification and treatment. It is the goal of this chapter to broaden the understanding of pediatric neuropsychologists and other child clinical specialists about the movement disorders, and to encourage further consideration of co-occurring disorders, such as Attention Deficit Hyperactivity Disorder (ADHD) and Obsessive-Compulsive Disorder (OCD), that often complicate the diagnosis and treatment of movement disorders in children (Pliszka, Carlson & Swanson, 1999).

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Acosta, M. & Castellanos, F. (2004). Use of the “inverse neuroleptic” metoclopramide in Tourette syndrome: An open case series. Journal of Child and Adolescent Psychopharmacology. 14, 123–8.CrossRefGoogle Scholar
American Psychiatric Association. (2000). Diagnostic and Statistical Manual of the Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR). Washington, DC: Author.
Asbahr, F., Negrao, A., Gentil, V.et al. (1998). Obsessive-compulsive and related symptoms in children and adolescents with rheumatic fever with and without chorea: A prospective 6-month study. American Journal of Psychiatry, 155, 1122–4.CrossRefGoogle ScholarPubMed
Azrin, N. H. & Peterson, A. L. (1990). Treatment of Tourette's syndrome by habit reversal: A waiting list control group comparison. Behavior Therapy, 21, 305–18.CrossRefGoogle Scholar
Barkley, R. (2005). Attention deficit hyperactivity disorder: A handbook for diagnosis and treatment, 3rd edn. New York: Guilford Press.Google Scholar
Bradshaw, J. L. (2001). Developmental disorders of the frontostriatal system: Neuropsychological, neuropsychiatric, and evolutionary perspectives. Phildadelphia, PA: Taylor & Francis, Inc.Google Scholar
Brown, R. & Ievers, C. (1999). Gilles de la Tourette syndrome. In Goldstein, S. & Reynolds, C. (eds.), Handbook of Neurodevelopmental and genetic disorders in children. New York: Guilford Press, pp. 185–215.Google Scholar
Castellanos, F. X. (1997). Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: Effects of stimulant and dose. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 589–96.CrossRefGoogle ScholarPubMed
Castellanos, F. X. (1999). Stimulants and tic disorders: From dogma to data. Archives of General Psychiatry, 56, 337–8.CrossRefGoogle ScholarPubMed
Church, A., Dale, R., Lees, A., Giovanni, G. & Robertson, M. (2003). Tourette's syndrome: A cross sectional study to examine the PANDAS hypothesis. Journal of Neurology, Neurosurgery, and Psychiatry, 74, 602–7.CrossRefGoogle ScholarPubMed
Como, P. & Kurlan, R. (1991). An open-label trial of Fluoxetine for obsessive-compulsive disorder in Gilles de la Tourette syndrome. Neurology, 41, 872–4.CrossRefGoogle Scholar
Cuker, A., State, M. W., King, R. A., Davis, N. & Ward, D. C. (2003). Candidate locus for Gilles de la Tourette syndrome/obsessive compulsive disorder/chronic tic disorder at 18q22. American Journal of Medical Genetics, 130A, 37–9.CrossRefGoogle Scholar
Cummings, D., Singer, H., Krieger, M., Miller, T. & Mahone, E. M. (2002). Neuropsychiatric effects of guanfacine in children with mild Tourette syndrome: A pilot study. Clinical Neuropharmacology, 25, 325–32.CrossRefGoogle ScholarPubMed
Dale, R. C. (2003). Autoimmunity and the basal ganglia: New insights into old diseases. Quarterly Journal of Medicine, 96, 183–91.CrossRefGoogle ScholarPubMed
Groot, C. M., Yeates, K. O., Baker, G. B. & Bornstein, R. A. (1997). Impaired neuropsychological functioning in Tourette's syndrome subjects with co-occurring obsessive-compulsive and attention deficit symptoms. Journal of Neuropsychiatry and Clinical Neuroscience, 9, 267–72.Google ScholarPubMed
Delgado, M., Albright, R. & Leland, A. (2003). Movement disorders in children: Definitions, classifications, and grading systems. Journal of Child Neurology, 18, 1–15.CrossRefGoogle ScholarPubMed
Dewey, D., Tupper, D. E. & Bottos, S. (2004). Involuntary motor disorders in childhood. In Dewey, D. & Tupper, D. E. (eds.), Developmental motor disorders: A neuropsychological perspective. New York: Guilford Press, pp. 197–210.Google Scholar
Gaffney, G., Perry, P., Lund, B.et al., (2002). Risperidone versus Clonidine in the treatment of children and adolescents with Tourette's syndrome. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 330–6.Google Scholar
Gambardella, A., Miglia, M., Labate, A.et al. (2001). Juvenile Huntington's disease presenting as progressive myoclonic epilepsy. Neurology, 57, 708–11.CrossRefGoogle ScholarPubMed
Garvey, M. & Swedo, S. (1997). Sydenham's chorea: Clinical and therapeutic update. Advances in Experimental and Medical Biology, 418, 115–20.CrossRefGoogle ScholarPubMed
Giedd, J., Rapoport, J., Garvey, M, Perlmutter, S. & Swedo, S. (2000). MRI assessment of children with obsessive-compulsive disorder or tics associated with streptococcal infection. American Journal of Psychiatry, 157, 281–3.CrossRefGoogle ScholarPubMed
Giedd, J., Rapoport, J., Kruesi, M. et al., (1995). Sydenham's chorea: magnetic resonance imaging of the basal ganglia. Neurology, 45, 2199–202.CrossRef
Gomez-Tortosa, E., Barrio, A., Ruiz, P. et al. (1998). Severity of cognitive impairment in juvenile and late-onset Huntington disease. Archives of Neurology, 55, 835–43.CrossRefGoogle ScholarPubMed
Hoogduin, K., Verdellen, C. & Cath, D. (1997). Exposure and response prevention in the treatment of Gilles de la Tourette's syndrome: Four case studies. Clinical Psychology and Psychotherapy, 4, 125–37.3.0.CO;2-Z>CrossRefGoogle Scholar
Hunter, S., Palumbo, D., Lou, J. & Tan, G. (1999, April). Auditory attention and sensory gating in Tourette syndrome and Attention Deficit Hyperactivity Disorder. Paper presented to the Second International Conference on Attention Deficit Hyperactivity Disorder, Tel Aviv, Israel.
Jankovic, J. (2001). Tourette's syndrome. The New England Journal of Medicine, 345, 1184–92.CrossRefGoogle ScholarPubMed
Jimenez-Jimenez, F. J. & Garcia-Ruiz, P. J. (2001). Pharmacological options for the treatment of Tourette's disorder. Drugs, 61, 2207–20.CrossRefGoogle ScholarPubMed
Kelsey, D., Sumner, C., Casat, C.et al. (2004). Once-daily atomoxetine treatment for children with attention deficit/hyperactivity disorder, including an assessment of evening and morning behavior: A double-blind, placebo-controlled trial. Pediatrics, 114, e1–e8.CrossRefGoogle ScholarPubMed
Kossoff, E. & Singer, H. (2001). Tourette syndrome: Clinical characteristics and current management strategies. Paediatric Drugs, 3 (Suppl.), 355–63.CrossRefGoogle ScholarPubMed
Kurlan, R. (1994). Hypothesis II: Tourette's syndrome is part of a clinical spectrum that includes normal brain development. Archives of Neurology, 51, 1145–50.CrossRefGoogle ScholarPubMed
Kurlan, R. (1997). Tourette syndrome: Treatment of tics. Neurologic Clinics, 15, 403–9.CrossRefGoogle ScholarPubMed
Kurlan, R. (2001). Methylphenidate to treat ADHD is not contraindicated in children with tics. Movement Disorders, 17, 5–6.CrossRefGoogle Scholar
Kurlan, R. (2003). Tourette's syndrome: Are stimulants safe?Current Neurology and Neuroscience Report, 3, 285–8.CrossRefGoogle ScholarPubMed
Kurlan, R. (2004). The PANDAS hypothesis: Losing its bite?Movement Disorders, 19, 371–4.CrossRefGoogle ScholarPubMed
Leckman, J. (2002). Tourette's syndrome. Lancet, 360, 1577–86.CrossRefGoogle ScholarPubMed
Leckman, J. F. & Cohen, D. J. (1999). Tourette's syndrome – Tics, obsessions compulsions: Developmental psychopathology and clinical care. New York: John Wiley & Sons, Inc.Google Scholar
Lennox, B. (2003). The neuropsychiatry of movement disorders. Current Opinion in Psychiatry, 16, 333–6.CrossRefGoogle Scholar
Mazei-Robison, M. S., Couch, R. S., Shelton, R. C., Stein, M. A. & Blakely, R. D. (2005). Sequence variation in the human dopamine transporter gene in children with attention deficit hyperactivity disorder. Neuropharmacology, 49, 724–36.CrossRefGoogle ScholarPubMed
Mazei-Robison, M. S., Couch, R. S., Shelton, R. C., Stein, M. A. & Blakely, R. D. MTA Cooperative Group (1999). 14-month randamized clinical trial of treatment strategies for ADHD. Archives of General Psychiatry, 56, 1073–1085.Google Scholar
Nance, M. (2001). The juvenile HD handbook: A guide for physicians, neurologists, and other professionals. New York: Huntington's Disease Society of America.Google Scholar
Nance, M. & Myers, R. (2001). Juvenile onset Huntington's disease: Clinical and research perspectives. Mental Retardation and Developmental Disabilities, 7, 153–7.CrossRefGoogle ScholarPubMed
Nicolson, R., Craven-Thuss, B., Smith, J., McKinlay, B. & Castellanos, F. X. (2005). A randomized, double-blind, placebo-controlled trial of metoclopramide for the treatment of Tourette's disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 44, 640–6.CrossRefGoogle ScholarPubMed
Palumbo, D., Maughan, A. & Kurlan, R. (1997). Hypothesis III: Tourette syndrome is only one of several causes of a developmental basal ganglia syndrome. Archives of Neurology, 54, 475–83.CrossRefGoogle ScholarPubMed
Palumbo, D., Spencer, T., Lynch, J., Co-Chien, H. & Faraone, S. (2004). Emergence of tics in children with ADHD: Impact of once-daily OROS Methylphenidate therapy. Journal of Child and Adolescent Psychopharmacology, 14, 185–94.CrossRefGoogle ScholarPubMed
Pliszka, S. R., Carlson, C. L. & Swanson, J. M. (1999). ADHD with comorbid disorders: Clinical assessment and management. New York: Guilford Press.Google Scholar
Pranzatelli, M. (1992). The neurobiology of the opsoclonus-myoclonus syndrome. Clinical Neuropharmacology, 15, 186–228.CrossRefGoogle ScholarPubMed
Pranzatelli, M. (1995). Update on pediatric movement disorders. Advances in Pediatrics, 42, 415–63.Google ScholarPubMed
Pranzatelli, M. (1996). The immunopharmacology of the opsoclonus-myoclonus syndrome. Clinical Neuropharmacology, 19, 1–47.CrossRefGoogle ScholarPubMed
Pranzatelli, M. (2003). A forward look at therapy for pediatric movement disorders. Seminars in Pediatric Neurology, 10, 103–10.CrossRefGoogle Scholar
Robertson, M. (2006). Attention deficit hyperactivity disorder, tics, and Tourette's syndrome: The relationship and treatment implications. A commentary. European Child and Adolescent Psychiatry, 15, 1–11.CrossRefGoogle ScholarPubMed
Sandor, P. (2003). Pharmacological management of tics in patients with TS. Journal of Psychosomatic Research, 55, 41–8.CrossRefGoogle ScholarPubMed
Scahill, L., Riddle, M., King, R.et al. (1997). Fluoxetine has no marked effect on tic symptoms in patients with Tourette's syndrome: A double-blind placebo-controlled study. Journal of Child and Adolescent Psychopharmacology, 7, 75–85.CrossRefGoogle ScholarPubMed
Singer, H. S., Loiselle, C. R., Lee, O. et al. (2004). Anti-basal ganglia antibodies in PANDAS. Movement Disorders, 19, 406–15.CrossRefGoogle ScholarPubMed
Spencer, T., Biederman, J., Coffey, B. et al. (1999). The 4-year course of tic disorders in boys with attention deficit/hyperactivity disorder. Archives of General Psychiatry, 56, 842–7.CrossRefGoogle ScholarPubMed
Spencer, T., Biederman, J., Faraone, S. et al. (2001). Impact of tic disorders on ADHD outcome across the life cycle: Findings from a large group of adults with and without ADHD. American Journal of Psychiatry, 158, 611–17.CrossRefGoogle ScholarPubMed
Stahl, S. (1988). Basal ganglia neuropharmacology and obsessive-conpulsive disorder: The obsessive-compulsive disorder hypothesis of basal ganglia dysfunction. Psychopharmacology Bulletin, 24, 370–4.Google ScholarPubMed
Stein, M. A., Waldman, I. D., Sarampote, C. S. et al. (2005). Dopamine transporter genotype and methylphenidate dose response in children with ADHD. Neuropsychopharmacology, 30, 1374–82.CrossRefGoogle ScholarPubMed
Stern, E., Silbersweig, D., Chee, K. et al. (2000). A functional neuroanatomy of tics in Tourette syndrome. Archives of General Psychiatry, 57, 741–8.CrossRefGoogle ScholarPubMed
Swedo, S. E. (1994). Sydenham's chorea: A model for childhood autoimmune neuropsychiatric disorders. Journal of the American Medical Association, 272, 1788–91.CrossRefGoogle ScholarPubMed
Swedo, S., Leonard, H., Mittleman, B. et al. (1997). Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever. American Journal of Psychiatry, 154, 110–12.Google Scholar
Swedo, S., Leonard, H., Garvey, M.et al. (1998). Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: Clinical descriptions of the first 50 cases. American Journal of Psychiatry, 155, 264–71.Google Scholar
Tellenius, H., Kremer, H., Theilmann, J. et al. (1993). Molecular analysis of juvenile Huntington's disease: The major influence on CAGn repeat length is the sex of the affected parent. Human Molecular Genetics, 2, 1535–40.CrossRefGoogle Scholar
The Tourette Syndrome Study Group. (2002). Treatment of ADHD in children with tics: A randomized controlled trial. Neurology, 58, 527–36.CrossRef
Vargas, A. P., Carod-Artal, F. J., Vazquez-Cabrera, C. & Dantas-Barbosa, C. (2003). Unusual early-onset Huntington's disease. Journal of Child Neurology, 18, 429–32.CrossRefGoogle Scholar
Verdellen, C. W. J., Keijsers, G. P. J., Cath, D. C. & Hoogduin, C. A. L. (2004). Exposure with response prevention versus habit reversal in Tourette's syndrome: A controlled study. Behaviour Research and Therapy, 42, 501–11.CrossRefGoogle ScholarPubMed
Voelker, R. (2004). Scientists use neuroimaging, genetic studies to probe biology of Tourette syndrome. Journal of the American Medical Association, 292, 909–11.Google ScholarPubMed
Walker, K., Lawrenson, J. & Whilmshurst, J. (2005). Neuropsychiatric movement disorders following streptococcal infection. Developmental Medicine and Child Neurology, 47, 771–5.CrossRefGoogle ScholarPubMed
Woods, D. W. (2005). Introduction to the special issue on the clinical management of Tourette's syndrome: A behavioral perspective. Behavior Modification, 29, 711–15.CrossRefGoogle Scholar
Woods, D. W., Hook, S. S., Spellman, D. F. & Friman, P. C. (2000). Case study: Exposure and response prevention for an adolescent with Tourette's syndrome and OCD. Journal of the American Academy of Child & Adolescent Psychiatry, 39, 904–7.CrossRefGoogle ScholarPubMed
Yeates, K. O. & Bornstein, R. A. (1996). Neuropsychological correlates of learning disability subtypes in children with Tourette's syndrome. Journal of the International Neuropsychological Society, 2, 375–82.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×